ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1596 • 2012 ACR/ARHP Annual Meeting

    Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy

    Jean-Yves Reginster1, R. Chapurlat2, Claus Christiansen3, H. Genant4, N. Bellamy5, W. Bensen6, F. Navarro7, J. Badurski8, E. Nasonov9, X. Chevalier10, PN. Sambrook11, T. Spector12 and Cyrus Cooper13, 1Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, 2Service de Rhumatologie et Pathologie Osseuse, INSERM UMR 1033 and Université de Lyon, Hôpital Edouard Herriot, Lyon, France, 3CCBR, Ballerup, Denmark, 4Radiology, Medicine and Orthopaedic Surgery University of California and Synarc, San Francisco, CA, 5CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, 6St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 7Servicio de Reumatologia, H. Universitario Virgen de la Macarena, Sevilla, Spain, 8Center of Osteoporosis and Osteo-articular Diseases, Bialystock, Poland, 9ARBITER, Inst of Rheumatology, Moscow, Russia, 10Service de Rhumatologie, Hôpital Henri-Mondor, Creteil, France, 11Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia, 12Dept of Twin Research and Genetic Epidemiology, King's College London, St. Thomas Campus, London, United Kingdom, 13NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom

    Background/Purpose: Treatments for osteoarthritis focus on improving symptoms through non-pharmacological and pharmacological approaches. Strontium ranelate (SrRan), a treatment for osteoporosis, was shown to stimulate cartilage…
  • Abstract Number: 1557 • 2012 ACR/ARHP Annual Meeting

    What Percentage of Postmenopausal Women Younger Than Age 65 Years Have Low Bone Mineral Density At a Family Health Center?

    Marvin Vaishnani1 and Feyrouz T. Al-Ashkar2, 1Rheumatic and Immunologic diseases, Cleveland Clinic,Lorain Institute, Lorain, OH, 2Rheumatic and Immunologic Diseases, Cleveland Clinic,Lorain Institute, Lorain, OH

    Background/Purpose: Many younger women, < 65 years of age may have low bone mineral density (BMD) that remains undetected in clinical practice due to following…
  • Abstract Number: 1558 • 2012 ACR/ARHP Annual Meeting

    “It Gets Me Down Every Single Day”: Are Men with Rheumatoid Arthritis Getting the Support They Need?

    Caroline A. Flurey1, Marianne Morris2, Jon Pollock1, Rodney A. Hughes3, Pamela Richards4 and Sarah Hewlett5, 1Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom, 2University of the West of England, Bristol, United Kingdom, 3Rheumatology, St. Peters Hospital, Chertsey Surrey, United Kingdom, 4Academic Rheumatology Unit, University of Bristol, Bristol, United Kingdom, 5Academic Rheumatology, University of the West of England, Bristol, United Kingdom

    Background/Purpose: Daily life with RA has been explained as unpredictable and full of uncertainty. However, most research about daily life with RA was conducted before…
  • Abstract Number: 1559 • 2012 ACR/ARHP Annual Meeting

    Treatment Outcomes From a Nurse-Led Rheumatology Clinic in Monitoring of anti-TNF Therapy – a Randomised Controlled Trial

    Ingrid Larsson1, Bengt Fridlund1, Barbro Arvidsson2, Annika Teleman3 and Stefan Bergman4, 1Jönköping University, Jönköping, School of Health Sciences, Jönköping University, Jönköping, Sweden, 2Halmstad University, School of Social and Health Sciences, Halmstad University, Halmstad, Sweden, 3Spenshults Hosp of Rheum Dis, Oskarstrom, Sweden, 4Spenshult Hospital, R&D Center, Spenshult Hospital, Oskarström, Sweden

    Background/Purpose: Patients with chronic inflammatory arthritis (CIA) treated with anti-TNF therapy are usually followed up by rheumatologists. Nurse-led rheumatology clinics have been proposed for patients…
  • Abstract Number: 1560 • 2012 ACR/ARHP Annual Meeting

    What Will Determine Adherence to Pharmaceutical Treatment for Rheumatoid Arthritis? A Systematic Review

    Annelieke Pasma1, Adriaan van 't Spijker2, Jan van Busschbach3, Johanna M.W. Hazes4 and Jolanda J. Luime5, 1Rheumatology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 2Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC University Medical Center, Rotterdam, Netherlands, 3Medical Psychology and Psychotherapy, Erasmus MC - University Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus MC, Rotterdam, Netherlands, 5Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands

    Background/Purpose: In the early stages of Rheumatoid Arthritis (RA), adherence to the prescribed treatment is important to prevent irreversible joint damage. However, medication adherence rates…
  • Abstract Number: 1561 • 2012 ACR/ARHP Annual Meeting

    Factors Influencing Implementation of Intensive Treatment Strategies for Early Rheumatoid Arthritis

    Sabrina Meyfroidt1, Diederik De Cock1, Kristien Van der Elst2, Laura van Hulst3, Marlies Hulscher3, Johan Joly4, Rene Westhovens5 and Patrick Verschueren5, 1Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium, 2Department of Development and Regeneration, Neuro-musculo-skeletal Research Unit, University Hospitals KULeuven, Leuven, Belgium, 3Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4University Hospitals Leuven on behalf of the CareRA Study Group, Leuven, Belgium, 5Rheumatology, University Hospitals KULeuven, Leuven, Belgium

    Background/Purpose: Despite the availability and demonstrated effectiveness of intensive treatment strategies for early rheumatoid arthritis (RA), a discrepancy seems to exist between theoretical acceptance and…
  • Abstract Number: 1562 • 2012 ACR/ARHP Annual Meeting

    Benign Joint Hypermobility Syndrome More Common Than Expected,Both in Controls and in SLE Patients

    Pia Malcus-Johnsson1, Lotta Köhlin1, Gunnar K. Sturfelt2 and Ola Nived3, 1Department of Rheumatology, University Hospital, Lund, Sweden, 2Department of Rheumatology, University Hospital Lund, Lund, Sweden, 3Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden

    Background/Purpose: Benign joint hypermobility syndrome(BJHS) in connection to rheumatic disease is sparsely investigated. It has been postulated that BJHS is more frequent in SLE than…
  • Abstract Number: 1563 • 2012 ACR/ARHP Annual Meeting

    Is Automated DATA Capture As Reliable As Manual DATA Entry in Survey Based Research?

    Rachel A. Mikolaitis1, Jessica Cornejo2, Chris Alonzo1, Joel A. Block1 and Meenakshi Jolly2, 1Section of Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: The collection of patient reported outcomes requires accruing survey data from patients during routine medical visits. Many of these are paper-based and require manual…
  • Abstract Number: 1564 • 2012 ACR/ARHP Annual Meeting

    Misperceptions of FMS Patients about Their Disease

    Robert S. Katz1, Hannah Bond2, Jessica L. Polyak2, Lauren Kwan2 and Susan Shott1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates, Chicago, IL

    Background/Purpose: What do fibromyalgia patients think causes their illness. We asked fibromyalgia syndrome patients to respond to a questionnaire which asked about potential etiologic factors.…
  • Abstract Number: 1565 • 2012 ACR/ARHP Annual Meeting

    How FMS Patients Become Workaholics

    Robert S. Katz1, Hannah Bond2, Jessica L. Polyak2, Lauren Kwan2 and Susan Shott1, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates, Chicago, IL

    Background/Purpose: Many patients with the fibromyalgia syndrome (FMS) bring in disability forms for the practitioner to fill out or have Social Security Disability applications requesting medical…
  • Abstract Number: 1566 • 2012 ACR/ARHP Annual Meeting

    Fibromyalgia’s Impact On Relationships

    Robert S. Katz1, Alexandra Small2, Sharon M. Ferbert3 and Susan Shott1, 1Rush University Medical Center, Chicago, IL, 2University of Illinois Medical School, Chicago, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL

    Background/Purpose: The Fibromyalgia Syndrome (FMS) can place a strain on patients’ personal relationships. Having a close support network is helpful in coping with illnesses, but chronic…
  • Abstract Number: 1567 • 2012 ACR/ARHP Annual Meeting

    Sleep Study with Armband Device in Fibromyalgia Patients: Fibromyalgia Patients Don’t Rest Their Weary Muscles

    Robert S. Katz1, Alexandra Small2, Ben J. Small3 and Jessica L. Polyak4, 1Rush University Medical Center, Chicago, IL, 2University of Illinois Medical School, Chicago, IL, 3MacNeal Hospital, Berwyn, IL, 4Rheumatology Associates, Chicago, IL

    Background/Purpose: Patients with the fibromyalgia syndrome (FMS) have frequent awakenings and poor sleep efficiency. The purpose of this study is to evaluate sleep patterns in…
  • Abstract Number: 1568 • 2012 ACR/ARHP Annual Meeting

    A Survey Study of Methotrexate Use by Rheumatologists and Their Patients with Rheumatoid Arthritis

    Peter Nash1 and Dave Nicholls2, 1University of Queensland, Brisbane, Australia, 2Coast Joint Care, Maroochydore, Australia

    Background/Purpose: Methotrexate (MTX) is the anchor medication for the management of rheumatoid arthritis (RA); however there is limited patient-focused data available on the use of…
  • Abstract Number: 1569 • 2012 ACR/ARHP Annual Meeting

    Optimizing Care for Patients with Rheumatoid Arthritis Newly Treated with Biologics by Evaluating Health Status with AIMS-2

    Mie Fusama1, Hideko Nakahara2, Keisuke Kawamoto3, Satoko Nozato3, Midori Taguchi3, Kohji Nishioka3, Shinji Higa3, Eiji Takeuchi4, Kayoko Higashi5, Masao Yukioka6, Tsuyoshi Igarashi3, Taro Kuritani3, Keiji Maeda3 and Yasushi Miura7, 1Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, 3Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, 4Department of Orthopaedic Surgery, NTT West Osaka Hospital, Osaka, Japan, 5Division of nursing, NTT West Osaka Hospital, Osaka, Japan, 6Department of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan, 7Department of Rehabilitation Science, Graduate School of Health Sciences, Kobe University, Kobe, Japan

    Background/Purpose: Biologics significantly improve disease activity of rheumatoid arthritis (RA), however, patient global assessment (PGA) is not always improved in parallel with disease activity scores.…
  • Abstract Number: 1570 • 2012 ACR/ARHP Annual Meeting

    Discrepancies Between Disease Activity and Disease Burden

    Margot J.M. Walter1, Adriaan van 't Spijker2, Annelieke Pasma3, Johanna M.W. Hazes4 and Jolanda J. Luime4, 1Rheumatology, Erasmus MC - University Medical Center, Rotterdam, Netherlands, 2Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus MC University Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands

    Background/Purpose: In a longitudinal study aiming to use patient self-reported disease activity measured by three domains: functional ability (HAQ), disease activity (RADAI) and fatigue (VAS)…
  • « Previous Page
  • 1
  • …
  • 2315
  • 2316
  • 2317
  • 2318
  • 2319
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology